CCHR Says Antipsychotic Drug Harm in the Face of Workable Alternatives is Blatantly Ignored
LOS ANGELES, Calif., March 2, 2026 (SEND2PRESS NEWSWIRE) — Seventy-two years after the first antipsychotic, Thorazine, was approved, psychiatry is now seriously discussing the need to deprescribe these drugs. For millions already exposed, that realization comes far too late. Despite decades of mounting evidence of severe and sometimes irreversible harm, new drugs in the same class continue to receive federal approval. The Citizens Commission on Human Rights International (CCHR) says this represents a systemic failure that demands urgent reform.